Total Hip Arthroplasty Instability and Lumbo-pelvic Kinematics: EOS Imaging Assessment of Variation in Spinal and Pelvic Parameters From Standing to Sitting
NCT ID: NCT03603470
Last Updated: 2020-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2018-07-06
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inverting Grayscale Improves Detection of Proximal Femur Fracture
NCT05318378
Preoperative Gluteal Muscle Atrophy: A Silent Predictor of THA Dislocation.
NCT06571604
Static Balance Disorders in Patients After Surgical Treatment of Hip Acetabular Fractures
NCT04902209
Contribution of Stereography (EOS Imaging System) in the Quantification of Femoral Shaft Fractures.
NCT03251534
Surgical Treatment of Pelvis in Fragility Fracture in Germany: a Prospective, National, Multicenter, Observational, Comparative Cohort Study Comparing Isolated Posterior Versus Combined Anterior-posterior Surgical Fracture Stabilization
NCT06550934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with previous prothesis instability
EOS imagery
Whole body EOS imaging in seated and standing position
Patients without prothesis instability
EOS imagery
Whole body EOS imaging in seated and standing position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EOS imagery
Whole body EOS imaging in seated and standing position
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* The patient must be at least 18 years old and less than 85 years old
* Patient has a conventional first intention total hip arthroplasty (not dual mobility) by posterior approach
* "Case" patients have at least one previous episode of prosthetic dislocation repaired with surgery
* "Control" patients have no previous episode of prosthetic dislocation with more than 2 year since initial intervention
Exclusion Criteria
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patient is under safeguard of justice or state guardianship
* Patient is pregnant, parturient or breastfeeding
* Patient with lumbar instrumentation
* Patient with severe dementia (Mini Mental State Examination \< 10)
* Patient with American Society of Anesthesiologists score ≥ 4
* Patient experience multiple falls
* Patient requiring early revision surgery (\<15 days postoperatively
* Patient with obvious implant positioning error on an X-ray of the pelvis.
* Patient with dislocation of traumatic origin (significant kinetic trauma)
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal Kouyoumdjian, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Nimes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Lapeyronie de Montpellier
Montpellier, , France
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOIGCSMERRI/2017/PK-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.